šŸ¤ Donate
Bills

AB 634: Tianeptine.

  • Session Year: 2025-2026
  • House: Assembly

Current Status:

In Progress

(2026-01-13: From committee: Do pass and re-refer to Com. on JUD. (Ayes 15. Noes 0.) (January 13). Re-referred to Com. on JUD.)

Introduced

First Committee Review

First Chamber

Second Committee Review

Second Chamber

Enacted

Version:

Existing law provides for the regulation of various chemicals, including chemicals contained in drugs, dietary supplements, and food products.

This bill would prohibit a person or entity from manufacturing, selling, delivering, distributing, holding, or offering for sale, in commerce a product that contains tianeptine. The bill would make a violation of these provisions punishable by a civil penalty not to exceed $5,000 for a first violation and not to exceed $10,000 for each subsequent violation, upon an action brought by the Attorney General, a city attorney, a county counsel, or a district attorney.

Existing law, the California Uniform Controlled Substances Act (the act), classifies controlled substances into 5 designated schedules, with the most restrictive limitations generally placed on controlled substances classified in Schedule I, and the least restrictive limitations generally placed on controlled substances classified in Schedule V. The act restricts the prescription, furnishing, possession, sale, and use of controlled substances, and makes a violation of those laws a crime, except as specified.This bill would add the substance tianeptine to Schedule I. By creating a new crime, the bill would establish a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.

Discussed in Hearing

Assembly Standing Committee on Judiciary6MIN
Jan 15, 2026

Assembly Standing Committee on Judiciary

Assembly Standing Committee on Health9MIN
Jan 13, 2026

Assembly Standing Committee on Health

View Older Hearings

News Coverage:

AB 634: Tianeptine. | Digital Democracy